Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 2 hrs 51 mins

S&P Futures
5,867.00
-29.25(-0.50%)
Dow Futures
42,975.00
-202.00(-0.47%)
Nasdaq Futures
20,394.50
-125.00(-0.61%)
Russell 2000 Futures
2,236.80
-18.70(-0.83%)
Crude Oil
71.22
+0.66(+0.94%)
Gold
2,748.80
+9.90(+0.36%)

Universe Pharmaceuticals INC (UPC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

0.4043

-0.0127

(-3.05%)

At close: 04:00PM EDT

0.3939

-0.01

(-2.57%)

After hours:

07:46PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	9.56M
Enterprise Value	4.68M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.05
Price/Book (mrq)	0.36
Enterprise Value/Revenue	0.18
Enterprise Value/EBITDA	0.31

Trading Information

Stock Price History

Beta (5Y Monthly)	1.57
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	4.3200
52 Week Low ³	0.1970
50-Day Moving Average ³	1.6473
200-Day Moving Average ³	2.2096

Share Statistics

Avg Vol (3 month) ³	3.51M
Avg Vol (10 day) ³	7.1M
Shares Outstanding ⁵	23.65M
Implied Shares Outstanding ⁶	N/A
Float ⁸	3.33M
% Held by Insiders ¹	8.80%
% Held by Institutions ¹	0.03%
Shares Short (Sep 30, 2024) ⁴	408.27k
Short Ratio (Sep 30, 2024) ⁴	0.09
Short % of Float (Sep 30, 2024) ⁴	1.89%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	1.73%
Shares Short (prior month Aug 30, 2024) ⁴	3M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Sep 30, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	-69.41%
Operating Margin (ttm)	-13.51%

Management Effectiveness

Return on Assets (ttm)	-5.65%
Return on Equity (ttm)	-50.22%

Income Statement

Revenue (ttm)	26.73M
Revenue Per Share (ttm)	7.35
Quarterly Revenue Growth (yoy)	-30.20%
Gross Profit (ttm)	N/A
EBITDA	-4.92M
Net Income Avi to Common (ttm)	-18.55M
Diluted EPS (ttm)	-5.0900
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	11.39M
Total Cash Per Share (mrq)	3.12
Total Debt (mrq)	6.51M
Total Debt/Equity (mrq)	24.34
Current Ratio (mrq)	1.63
Book Value Per Share (mrq)	7.34

Cash Flow Statement

Operating Cash Flow (ttm)	-6.11M
Levered Free Cash Flow (ttm)	-2.1M